Non-nucleoside reverse transcriptase inhibitor (NNRTI): Class Overview and Comparison
Quick answer: Non-nucleoside reverse transcriptase inhibitor (NNRTI) are a class of medicines used for specific therapeutic indications. iMedic covers 5 non-nucleoside reverse transcriptase inhibitor (nnrti) substances. Below is a comparison table linking to detailed pages for each.
Non-nucleoside reverse transcriptase inhibitor (NNRTI) on iMedic (5 substances)
| Substance | Primary indications | Mechanism | Common dose |
|---|---|---|---|
| Edurant | HIV-1 infection | Non-nucleoside inhibitor of HIV-1 reverse transcriptase blocking viral DNA synth | 25 mg once daily |
| Efavirenz | HIV-1 infection | Non-nucleoside inhibitor of HIV-1 reverse transcriptase blocking viral replicati | 600 mg once daily |
| Intelence | HIV-1 infection (treatment-experienced patients) | Etravirine binds directly to HIV-1 reverse transcriptase, blocking RNA- and DNA- | 200 mg twice daily after meals |
| Pifeltro | HIV-1 infection | Doravirine binds non-competitively to HIV-1 reverse transcriptase, blocking vira | 100 mg once daily |
| Viramune | HIV-1 infection | Binds directly to HIV-1 reverse transcriptase, blocking RNA- and DNA-dependent p | 200 mg once daily for 14 days, then 200 mg twice daily (or 400 mg XR once daily) |
About Non-nucleoside reverse transcriptase inhibitor (NNRTI)
Non-nucleoside reverse transcriptase inhibitor (NNRTI) share a common mechanism of action and clinical use. Specific dosing, side effects, contraindications, and drug interactions vary between individual substances within the class. Click any substance above for full prescribing information and patient guidance.
Common considerations across the class
- Indication-specific selection: Different members may be preferred for different conditions or patient populations
- Dose equivalence: Members of the same class are not always interchangeable on a 1:1 dose basis
- Drug interactions: Class members often share interaction profiles (e.g., CYP enzyme effects) but individual variation matters
- Side effects: Some side effects are class-wide; others are substance-specific
- Contraindications: Individual contraindications may not generalize across the class
Always consult the prescribing information for the specific medicine prescribed and discuss with your clinician.
Frequently asked questions
What are Non-nucleoside reverse transcriptase inhibitor (NNRTI)?
Non-nucleoside reverse transcriptase inhibitor (NNRTI) are medicines that share a common mechanism of action used for specific therapeutic indications. iMedic currently covers 5 substances in this class with detailed pages for each.
Are all Non-nucleoside reverse transcriptase inhibitor (NNRTI) interchangeable?
No. While medicines in the same class share a mechanism, they differ in potency, dosing, drug interactions, and tolerability. Switching between them is a clinical decision based on individual response, side effects, and treatment goals.
How do I choose between different Non-nucleoside reverse transcriptase inhibitor (NNRTI)?
Selection depends on the specific clinical indication, patient factors (age, comorbidities, kidney/liver function, other medications), tolerability of side effects, cost, and clinician preference. This is a prescribing decision.
Are Non-nucleoside reverse transcriptase inhibitor (NNRTI) available as generics?
Most well-established class members are available as generic alternatives, often substantially less expensive than brand-name versions while clinically equivalent. Newer members may still be brand-only.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.